Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of six antibodies specific to dupilumab (Dupixent) and the addition of new evolocumab (Repatha), ipilimumab (Yervoy), and secukinumab (Cosentyx) antibodies.

See Which States Have the Most High-Performing Hospitals for Maternity Care

For expectant parents considering where to seek maternity care, these 311 facilities earned top marks on this year’s “Best Hospitals for Maternity Care” list from

December 6, 2023

U.S. News & World Report Integrates 3M AM-PPCs with Best Hospitals Specialty Rankings

by Jasmine Pennic 07/14/2023 Leave a Comment What You Should Know: U.S. News & World Report will incorporate the 3M™ Ambulatory Potentially Preventable Complications (3M

July 15, 2023

Does dahlia flower extract have anti-diabetic properties?

The effects of an extract of yellow petals of Dahlia pinnata as a novel treatment of type 2 diabetes (T2D).

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.